NCT01166789View on ClinicalTrials.gov

Lubiprostone Effects on Visceral Pain Sensitivity

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Lubiprostone

48ug daily taken as 24ug capsules twice per day, in morning and evening.

DRUG

Placebo

2 capsules daily, taken in morning and evening

Trial Locations (1)

27599

UNC Clinical and Translational Research Center, Chapel Hill

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER